25 news items
Actinium Pharmaceuticals (ATNM) Poised for Breakout as Analysts Project Significant Upside
CRMD
FULC
MRNS
9 May 24
with its pioneering targeted radiotherapies.
A Focused Approach on High-Impact Therapies
HC Wainwright & Co. Maintains Buy on Ocular Therapeutix, Lowers Price Target to $14
OCUL
8 May 24
HC Wainwright & Co. analyst Yi Chen maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and lowers the price target from $16 to $14.
JMP Securities Maintains Market Outperform on Ocular Therapeutix, Lowers Price Target to $22
OCUL
8 May 24
JMP Securities analyst Jonathan Wolleben maintains Ocular Therapeutix (NASDAQ:OCUL) with a Market Outperform and lowers the price target from $24 to $22.
TD Cowen Maintains Hold on Ocular Therapeutix, Lowers Price Target to $7
OCUL
8 May 24
TD Cowen analyst Tara Bancroft maintains Ocular Therapeutix (NASDAQ:OCUL) with a Hold and lowers the price target from $11 to $7.
BioNTech Reports Downbeat Earnings, Joins Medical Properties Trust And Other Big Stocks Moving Lower In Monday's Pre-Market Session
ADCT
BNTX
LAZR
6 May 24
Equal-Weight to Underweight and lowered the price target from $19 to $15.
Now Read
w5i7c6syu1 gwqth4p9g2dn
OCUL
3 May 24
containing the words "anticipate", "believe", "estimate", "expect", "intend", "goal", "may", "might", "plan", "predict", "project", "target", "potential
07m756zcbukjibvbj9s11mhejxkyn2pdmq8523ifyi xot74
OCUL
1 May 24
", "expect", "intend", "goal", "may", "might", "plan", "predict", "project", "target", "potential", "will", "would", "could", "should", "continue
lwjnt26m2b1fmezu1 ukyih
OCUL
19 Apr 24
HC Wainwright & Co. analyst Yi Chen reiterates Ocular Therapeutix (NASDAQ:OCUL) with a Buy and maintains $16 price target.
ws3hoxywqdrro7tthtk6120ihy35 vf1lg09pv4wqbi5wb
AGBA
ALRN
APOG
18 Apr 24
Thalmann analyst Aydin Huseynov maintained Aileron Therapeutics with a Buy and raised the price target from $9 to $19.
MicroCloud
r9x 18xale9r
OCUL
18 Apr 24
axitinib, a small molecule, multi-target, tyrosine kinase inhibitor with anti-angiogenic properties, being evaluated for the treatment of wet AMD, DR
1n75im27ji6632aoecurugk2elay pw7u
OCUL
16 Apr 24
0
Analysts have recently evaluated Ocular Therapeutix and provided 12-month price targets. The average
ppjciue151xn0 lpnfzjqf2
OCUL
16 Apr 24
JMP Securities analyst Jonathan Wolleben reiterates Ocular Therapeutix (NASDAQ:OCUL) with a Market Outperform and maintains $24 price target.
mrwtux77sgpkuq8tv qvc
OCUL
16 Apr 24
", "might", "plan", "predict", "project", "target", "potential", "will", "would", "could", "should", "continue
6we 6aehrgpqzozzrjhqdv7
OCUL
6 Apr 24
", "estimate", "expect", "intend", "goal", "may", "might", "plan", "predict", "project", "target
13beed6y2tb3pe br94d4tozaq7wvbajk8l
OCUL
13 Mar 24
JMP Securities analyst Jonathan Wolleben reiterates Ocular Therapeutix (NASDAQ:OCUL) with a Market Outperform and maintains $24 price target.
4z69vd7152o290kb90gwxatolacvzoun5ii048r sp0e1e
OCUL
13 Mar 24
0
Analysts provide deeper insights through their assessments of 12-month price targets, revealing
ag86bonul31sh ryg
OCUL
13 Mar 24
HC Wainwright & Co. analyst Yi Chen maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and raises the price target from $12 to $15.
3hoaxfxrkep7ll5g5knbac c9gwy
ACAD
ADM
AEVA
12 Mar 24
and raised its price target from $5 to $7.
Singularity Future Technology Ltd
cvo6hwdaz7iwhvey0f08zq2a1g9ff6z4n
OCUL
12 Mar 24
Therapeutix shares dipped 6.7% to trade at $9.08 on Tuesday.
These analysts made changes to their price targets on Ocular Therapeutix after
naay9yhgmgbzgzopq6b506gstskzvj74adqc6mokp
OCUL
12 Mar 24
TD Cowen analyst Tara Bancroft maintains Ocular Therapeutix (NASDAQ:OCUL) with a Market Perform and raises the price target from $8 to $11.